159 related articles for article (PubMed ID: 33045593)
1. Synthesis, structural characterization, and prospects for new cobalt (II) complexes with thiocarbamoyl-pyrazoline ligands as promising antifungal agents.
Dias BB; da Silva Dantas FG; Galvão F; Cupozak-Pinheiro WJ; Wender H; Pizzuti L; Rosa PP; Tenório KV; Gatto CC; Negri M; Casagrande GA; de Oliveira KMP
J Inorg Biochem; 2020 Dec; 213():111277. PubMed ID: 33045593
[TBL] [Abstract][Full Text] [Related]
2. A Promising Copper(II) Complex as Antifungal and Antibiofilm Drug against Yeast Infection.
Gomes da Silva Dantas F; Araújo de Almeida-Apolonio A; Pires de Araújo R; Regiane Vizolli Favarin L; Fukuda de Castilho P; de Oliveira Galvão F; Inez Estivalet Svidzinski T; Antônio Casagrande G; Mari Pires de Oliveira K
Molecules; 2018 Jul; 23(8):. PubMed ID: 30049937
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of
Fonseca D; Leal-Pinto SM; Roa-Cordero MV; Vargas JD; Moreno-Moreno EM; Macías MA; Suescun L; Muñoz-Castro Á; Hurtado JJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31266213
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel complexes containing N-phenyl-1H-pyrazole moiety: Ni complex as potential antifungal and antiproliferative compound.
El-Gamel NE; Farghaly TA
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():469-75. PubMed ID: 23871973
[TBL] [Abstract][Full Text] [Related]
5. In vitro Antifungal Effects of Berberine Against
Xie Y; Liu X; Zhou P
Drug Des Devel Ther; 2020; 14():87-101. PubMed ID: 32021094
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of the activity of dithiocarbamate organoruthenium complexes against clinically relevant fungal pathogens.
Donnici CL; Nogueira LJ; Araujo MH; Oliveira SR; Magalhães TF; Lopes MT; Araújo e Silva AC; Ferreira AM; Martins CV; de Resende Stoianoff MA
Molecules; 2014 Apr; 19(4):5402-20. PubMed ID: 24879585
[TBL] [Abstract][Full Text] [Related]
9. Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains.
R M Machado GD; Pippi B; Dalla Lana DF; Amaral AP; Teixeira ML; Souza KC; Fuentefria AM
Pharm Biol; 2016 Nov; 54(11):2410-2419. PubMed ID: 27050162
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
[TBL] [Abstract][Full Text] [Related]
11. Antifungal and anti-biofilm activity of a new Spanish extract of propolis against Candida glabrata.
Fernández-Calderón MC; Hernández-González L; Gómez-Navia C; Blanco-Blanco MT; Sánchez-Silos R; Lucio L; Pérez-Giraldo C
BMC Complement Med Ther; 2021 May; 21(1):147. PubMed ID: 34020643
[TBL] [Abstract][Full Text] [Related]
12.
Tetz G; Collins M; Vikina D; Tetz V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
[TBL] [Abstract][Full Text] [Related]
13. Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms.
Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Lett Appl Microbiol; 2012 May; 54(5):383-91. PubMed ID: 22313289
[TBL] [Abstract][Full Text] [Related]
14. Promising Antifungal and Antibacterial Agents Based on 5-Aryl-2,2'-bipyridines and Their Heteroligand Salicylate Metal Complexes: Synthesis, Bioevaluation, Molecular Docking.
Burgart Y; Shchegolkov E; Shchur I; Kopchuk D; Gerasimova N; Borisevich S; Evstigneeva N; Zyryanov G; Savchuk M; Ulitko M; Zilberberg N; Kungurov N; Saloutin V; Charushin V; Chupakhin O
ChemMedChem; 2022 Feb; 17(3):e202100577. PubMed ID: 34783161
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
16. A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; Demirel R; Kaplancıklı ZA
Eur J Med Chem; 2015 Mar; 92():342-52. PubMed ID: 25576739
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
18. Attempts to Access a Series of Pyrazoles Lead to New Hydrazones with Antifungal Potential against
Negru G; Kamus L; Bîcu E; Shova S; Sendid B; Dubar F; Ghinet A
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641405
[TBL] [Abstract][Full Text] [Related]
19. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata.
Monteiro DR; Gorup LF; Silva S; Negri M; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Biofouling; 2011 Aug; 27(7):711-9. PubMed ID: 21756192
[TBL] [Abstract][Full Text] [Related]
20. Biguanides enhance antifungal activity against Candida glabrata.
Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
